A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease
Clinical trial NCT01526785 · TERMINATED
Trial details
- NCT number
- NCT01526785
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-12-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.